ClearPoint Neuro, Inc. (CLPT)
About ClearPoint Neuro, Inc.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $37.0M
- Net income
- -$25.5M
- Total assets
- $97.7M
- Market cap
- $386.6M
- Gross margin
- 60.9%
- Operating margin
- -62.9%
- Net margin
- -60.3%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $31.4M
- Cost of revenue
- $12.3M
- Gross profit
- $19.1M
- Operating expenses
- $38.9M
- Operating income
- -$19.7M
- Income tax
- $12.0K
- Net income
- -$18.9M
- EPS (basic)
- $-0.70
- EPS (diluted)
- $-0.70
Balance sheet
- Total assets
- $39.2M
- Current assets
- $33.4M
- Total liabilities
- $13.8M
- Current liabilities
- $10.4M
- Shareholders’ equity
- $25.4M
Cash flow
- Operating cash flow
- -$8.9M
- Investing cash flow
- -$275.0K
- Financing cash flow
- $6.2M
- Net cash flow
- -$3.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $386.6M
- EPS (diluted)
- $-0.7
- Shares outstanding
- 27.4M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 18, 2012
ClearPoint Neuro, Inc. (CLPT) Stock Price
- Reported a net loss of $25.5M in FY2025.
- Revenue grew 145% from FY2020 to FY2024.
- Gross margin of 60.9%, net margin -60.3%.
- Trading 52% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review ClearPoint Neuro, Inc..
Write a review
News about ClearPoint Neuro, Inc.
News & sentiment via Polygon.io
ClearPoint Neuro, Inc.: frequently asked questions
Is ClearPoint Neuro, Inc. an American company?
ClearPoint Neuro, Inc. is a US-based company headquartered in Solana Beach, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is ClearPoint Neuro, Inc. headquartered?
ClearPoint Neuro, Inc. is headquartered in Solana Beach, California, United States.
Is ClearPoint Neuro, Inc. publicly traded?
Yes — ClearPoint Neuro, Inc. is a publicly traded company. Its stock trades under the ticker symbol CLPT on the NASDAQ.
What does ClearPoint Neuro, Inc. do?
ClearPoint Neuro, Inc. is an American Medical Devices company in the Health & Beauty sector.
